China SXT Pharmaceuticals SXTC
NASDAQ SXTC
$2.41 -0.55 (-18.58%)
At close: Oct 2, 2026 · 4:00 PM EDT

China SXT Pharmaceuticals (SXTC) Income towards Parent Company (2017 - 2019)

Updated

China SXT Pharmaceuticals (SXTC) reported Income towards Parent Company of -$6.21 million for FY2026 (year ended Mar 31, 2026), compared with -$3.3 million in FY2025.

Analysis

China SXT Pharmaceuticals (SXTC) Income towards Parent Company (2017 - 2019) Analysis & Trends

Dating back to FY2017, China SXT Pharmaceuticals' Income towards Parent Company record includes 10 fiscal years.

  • The FY2026 figure ranks as the lowest annual Income towards Parent Company since FY2020.
  • According to Business Quant data, Income towards Parent Company came in at -$3.3 million in FY2025, -$3.1 million in FY2024, -$5.93 million in FY2023 and -$5.74 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 China SXT Pharmaceuticals 31,626.43 -85.92 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2019 -1.17 Mn
Dec 31, 2018 1.19 Mn
Mar 31, 2018 -541,655.00
Dec 31, 2017 1.19 Mn
API Access

China SXT Pharmaceuticals Income towards Parent Company API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=SXTC&period=max&api_key=YOUR_API_KEY